Position in OLMA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,921,682
+$4,795,747 QoQ
Shares Held
1,832,269
+50.7% QoQ
Ownership
2.09%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 182 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in OLMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. OLMA ranks #89 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in OLMA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,921,682 | 1,832,269 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $18,125,935 | 1,215,690 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,645,075 | 665,803 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $15,232,130 | 1,555,887 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $6,123,351 | 1,437,407 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,698,355 | 451,691 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $5,972,697 | 1,024,477 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,980,233 | 249,601 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $3,630,874 | 335,571 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $5,638,784 | 498,126 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $6,984,748 | 497,844 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $636,344 | 51,526 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $567,597 | 62,857 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $395,195 | 113,890 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $497,157 | 202,922 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $793,508 | 287,504 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,776,274 | 436,432 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,578,404 | 605,260 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $5,544,160 | 592,325 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,373,576 | 86,124 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,501,973 | 125,160 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,039,176 | 61,458 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,200,524 | 45,768 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||